FDA Import Refusal AEK-7427560-0/21/1 — Novartis Pharma AG
The FDA refused shipment AEK-7427560-0/21/1 from Novartis Pharma AG (Switzerland) on Jun 2, 2020. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 2, 2020
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75